MediPharm Labs Corp.

C$0.06As of Sun 8 Nov 2026, 12:00 UTC
TSX:LABSHealthcare
Country Canada
PE (Fwd) •••
TSR 8Y CAGR (33.05%)
Div yield —
ROE (13.22%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.84
PE TTM —
TSR TTM (20.00%)
Mkt cap C$25.63M
ROIC (15.70%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0586
(2.37%)
(72.83%)
Hold 6|0|1|9|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
6.61%
7.81%
25.12%
32.95%
Revenue$M
1.554
1.537
1.587
1.600
8.43%
7.47%
11.13%
6.85%
Peers (US$18.14M)
Cap (US$)
PE
15.00M
4.459x
18.13M
1.110x
Capital
TTM
5Y
10Y
Leveragex
0.435
0.109
0.105
EBIT/Intx
0.175
0.045
0.052
Own earn%
94.82
79.84
58.29
Sh yield%
21.24
18.81
18.67
Owners
Insiders/Inst%
14.73
41.17
Short interest%
5.54
SBC / revenue%
4.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
8–20
$1 testx
—
Incr. ROIC%
2